The import of Phenazone to France demonstrates a consistent declining trend from 2024 to 2028, beginning at 84.87 thousand kilograms in 2024 and forecasted to fall to 82.04 thousand kilograms by 2028. As of 2023, the volume stood at a higher figure compared to the forecasted values in subsequent years, implying a decreasing demand or a strategic shift in sourcing.
Year-on-year, the import volume declines modestly, signifying a gradual reduction in reliance or necessity for Phenazone imports into France. Over the five years, the Compound Annual Growth Rate (CAGR) reflects a steady decrease in import volume.
Future trends to watch for include potential changes in domestic production capacity, regulatory shifts affecting import dynamics, or evolving medical and pharmaceutical industry demands that could further influence Phenazone imports.
